Stress-induced trained immunity in cardiovascular disease
心血管疾病中压力诱导的免疫力训练
基本信息
- 批准号:10635427
- 负责人:
- 金额:$ 53.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-03-17 至 2028-07-31
- 项目状态:未结题
- 来源:
- 关键词:ArteriogramAtherosclerosisBiological AssayBone MarrowBone Marrow AspirationBone Marrow TransplantationCardiovascular DiseasesCardiovascular systemCatecholaminesCell CompartmentationCell ReprogrammingCellsChronicChronic stressCoronary ArteriosclerosisCoronary arteryDevelopmentDiseaseEpigenetic ProcessEventExposure toFamilial HypercholesterolemiaGlucocorticoidsHeart failureHematopoieticHematopoietic stem cellsHormonesHumanImageImmuneImmunityImmunologic MemoryIn VitroInfectionInflammationInflammatoryInnate Immune SystemInterventionLigationMetabolicMethodsModificationMultiomic DataMusMyelogenousMyeloid CellsMyelopoiesisMyocardial InfarctionOutcomePatientsPeripheralPhenotypePheochromocytomaPositron-Emission TomographyPsychosocial StressQuestionnairesReportingRestRisk FactorsSamplingSterilityStimulusStressSystemTestingTherapeuticTrainingVaccinationWorkbiobankcardiovascular risk factorclinical imagingclinical translationcohortexperiencefluorodeoxyglucose positron emission tomographyhigh riskhormonal signalshuman modelimmune imagingin vivoinsightmonocytemouse modelmultiple omicsnanobiologicoptogeneticsoxidized low density lipoproteinperceived stressprofiles in patientsprogenitorprogramsrecruitstem cells
项目摘要
PROJECT SUMMARY
In the last decade, emerging evidence has unveiled that the innate immune system retains long-
term epigenetic and metabolic changes after infection or vaccination. This de facto innate immune memory
has been termed ‘trained immunity’ and is characterized by myeloid cells’ hyper-responsiveness following
a subsequent stimulus. Recent work has shown that sterile atherogenic/inflammatory triggers, such as
oxidized LDL or catecholamines, similarly induce a trained immunity phenotype through epigenetic and
metabolic reprogramming of the myeloid compartment. The long-term persistence of trained immunity in
vivo is due to the reprogramming of hematopoietic stem and progenitor cells (HSPC) in the bone marrow.
We have recently reported that monocytes isolated from patients with risk factors for CVD, such as
familial hypercholesterolemia or pheochromocytoma, display a ‘trained’ phenotype. Importantly, in patients
with established coronary artery disease, we found HSPCs reprogrammed towards a pro-inflammatory
myeloid lineage. Project 2 will focus on stress-induced trained immunity’s mechanistic aspects in
cardiovascular disease patients and mouse models. Our central hypothesis is that chronic stress induces
trained immunity via HSPC reprogramming, which exacerbates the development of atherosclerosis and
worsens the outcome of cardiovascular events.
In Aim 1, we will use deep phenotyping and imaging to study patients at high risk for cardiovascular
events in order to obtain an integrated view of stress-induced reprogramming of the myeloid cell
compartment. In Aim 2, we will study mice that were exposed to chronic mild psychosocial stress or to key
hormonal signals that promote peripheral effects on stress, followed by a rest period of 4 weeks. After the
rest period, stressed cohorts and non-stressed controls will undergo coronary artery ligation or induction of
atherosclerosis to test the hypothesis that preceding stress or exposure to stress hormones activates
trained immunity, thus increasing myelopoiesis and consequently worsening cardiovascular disease.
Our unique ability to profile patients’ HSPCs at Radboudumc, the human models, and the mouse
models that mimic them will yield critical insights into the relationship between cardiovascular disease and
psychosocial stress.
项目概要
在过去的十年中,新出现的证据表明,先天免疫系统保留了长期的免疫功能。
感染或疫苗接种后的术语表观遗传和代谢变化,实际上是先天免疫记忆。
被称为“训练有素的免疫”,其特征是骨髓细胞在
最近的研究表明,无菌性动脉粥样硬化/炎症触发因素,例如
氧化的低密度脂蛋白或儿茶酚胺,同样通过表观遗传和诱导训练的免疫表型
骨髓训练隔室的代谢重编程免疫的长期持续性。
体内是由于骨髓中造血干细胞和祖细胞(HSPC)的重新编程所致。
我们最近报道,从具有 CVD 危险因素的患者中分离出单核细胞,例如
家族性高胆固醇血症或嗜铬细胞瘤,在患者中表现出“训练有素”的表型。
对于已确诊的冠状动脉疾病,我们发现 HSPC 被重新编程为促炎细胞
项目 2 将重点关注应激诱导的训练免疫的机制方面。
我们的中心假设是慢性压力会诱发心血管疾病患者和小鼠模型。
通过HSPC重编程训练免疫力,这会恶化动脉粥样硬化的发展
使心血管事件的结果恶化。
在目标 1 中,我们将使用深度表型分析和成像技术来研究心血管高风险患者
事件以获得应激诱导的骨髓细胞重编程的综合视图
在目标 2 中,我们将研究暴露于慢性轻度社会心理压力或钥匙的小鼠。
促进外周压力影响的荷尔蒙信号,然后是 4 周的休息期。
休息期间,应激组和非应激对照组将接受冠状动脉结扎或诱导
动脉粥样硬化,以检验先前的压力或暴露于压力荷尔蒙会激活的假设
训练免疫力,从而增加骨髓细胞生成,从而恶化心血管疾病。
我们在 Radboudumc 分析患者 HSPC、人体模型和小鼠的独特能力
模仿它们的模型将对心血管疾病和心血管疾病之间的关系产生重要的见解。
社会心理压力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Willem Mulder其他文献
Willem Mulder的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Willem Mulder', 18)}}的其他基金
Elucidating the role of trained immunity in kidney transplant patients
阐明训练有素的免疫力在肾移植患者中的作用
- 批准号:
10642596 - 财政年份:2023
- 资助金额:
$ 53.46万 - 项目类别:
Translational imaging and nanomedicine in inflammatory atherosclerosis
炎症性动脉粥样硬化的转化成像和纳米医学
- 批准号:
10116448 - 财政年份:2017
- 资助金额:
$ 53.46万 - 项目类别:
Anti-inflammatory nanoparticle formulations to treat atherosclerosis
治疗动脉粥样硬化的抗炎纳米颗粒制剂
- 批准号:
8696070 - 财政年份:2014
- 资助金额:
$ 53.46万 - 项目类别:
Anti-inflammatory nanoparticle formulations to treat atherosclerosis
治疗动脉粥样硬化的抗炎纳米颗粒制剂
- 批准号:
9279233 - 财政年份:2014
- 资助金额:
$ 53.46万 - 项目类别:
PET/MRI to study nanotherapy in atherosclerosis
PET/MRI 研究动脉粥样硬化的纳米疗法
- 批准号:
8962168 - 财政年份:2014
- 资助金额:
$ 53.46万 - 项目类别:
PET/MRI to study nanotherapy in atherosclerosis
PET/MRI 研究动脉粥样硬化的纳米疗法
- 批准号:
8801993 - 财政年份:2014
- 资助金额:
$ 53.46万 - 项目类别:
A Surface Activable Nanoemulsion platform for Breast Cancer Diagnosis and Therapy
用于乳腺癌诊断和治疗的表面活性纳米乳平台
- 批准号:
8699161 - 财政年份:2011
- 资助金额:
$ 53.46万 - 项目类别:
A Surface Activable Nanoemulsion platform for Breast Cancer Diagnosis and Therapy
用于乳腺癌诊断和治疗的表面活性纳米乳平台
- 批准号:
8917868 - 财政年份:2011
- 资助金额:
$ 53.46万 - 项目类别:
A Surface Activable Nanoemulsion platform for Breast Cancer Diagnosis and Therapy
用于乳腺癌诊断和治疗的表面活性纳米乳平台
- 批准号:
8507620 - 财政年份:2011
- 资助金额:
$ 53.46万 - 项目类别:
A Surface Activable Nanoemulsion platform for Breast Cancer Diagnosis and Therapy
用于乳腺癌诊断和治疗的表面活性纳米乳平台
- 批准号:
8327177 - 财政年份:2011
- 资助金额:
$ 53.46万 - 项目类别:
相似国自然基金
HMGCS2调控巨噬细胞训练免疫对动脉粥样硬化斑块“维稳”的机制研究
- 批准号:82373884
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
通过自主研发的AAV8-TBG-LOX-1基因治疗技术祛除支架区域氧化型低密度脂蛋白抑制支架内新生动脉粥样硬化研究
- 批准号:82370348
- 批准年份:2023
- 资助金额:47 万元
- 项目类别:面上项目
基于NLRP3炎性小体驱动的巨噬细胞焦亡研究穗花杉双黄酮抗动脉粥样硬化作用
- 批准号:82360786
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
基于HDAC10/PANX1探讨外源性褪黑素抑制巨噬细胞焦亡稳定动脉粥样硬化易损斑块的作用机制
- 批准号:82300511
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于仿生脂质纳米疫苗的动脉粥样硬化双重免疫治疗策略及机制研究
- 批准号:22305170
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Complement Protein C1q Regulation of Macrophage Metabolic Pathways
补体蛋白 C1q 对巨噬细胞代谢途径的调节
- 批准号:
10629550 - 财政年份:2023
- 资助金额:
$ 53.46万 - 项目类别:
Systems Genetics of Vascular Smooth Muscle Phenotypes
血管平滑肌表型的系统遗传学
- 批准号:
10771623 - 财政年份:2023
- 资助金额:
$ 53.46万 - 项目类别:
Whole genome sequence interpretation for lipids to discover new genes and mechanisms for coronary artery disease
脂质的全基因组序列解释,以发现冠状动脉疾病的新基因和机制
- 批准号:
10722515 - 财政年份:2023
- 资助金额:
$ 53.46万 - 项目类别:
The Role of Arylsulfatase in Vascular Calcification
芳基硫酸酯酶在血管钙化中的作用
- 批准号:
10658067 - 财政年份:2023
- 资助金额:
$ 53.46万 - 项目类别: